About Us
We’ve built an integrated commercial services platform. Greater success for clients. Better outcomes for patients.
EVERSANA is a leading independent provider of global services to the life sciences industry.
The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 670 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world
Discover Our Difference
Leaders
We’re driven by a diverse team of experienced leaders who understand the challenges facing today’s industry.
Insights
Stay on top of the latest industry trends and insights through our white papers, webinars and more.
We’re making headlines as we grow our team and expand our capabilities. See our most recent news here!
-
Media Contacts:
Matt Braun [email protected] -
February 11, 2026
EVERSANA Names Monica Avram Executive Vice President and Chief Legal Officer to Advance Governance, Compliance, and Enterprise Growth
-
November 6, 2025
EVERSANA Named AI Company of the Year by BioTech Breakthrough
-
October 23, 2025
OWP Pharmaceuticals Selects EVERSANA to Support U.S. Launch of SUBVENITE® (lamotrigine) Oral Suspension
-
October 16, 2025
Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™